ClinicalTrials.gg
CompletedNCT07886307Updated Oct 21, 2026

Comprehensive Intervention to Promote Adjustment in Adolescents With Type 1 Diabetes and Their Parents During Transfer of Health Care Responsibility

An interventional study of CONEXIÓN ADAPTAR - DM1 and Usual Care in Type 1 Diabetes Mellitus (T1DM), Parent and Adolescent, sponsored by Universidad de la Sabana. Completed at 2 sites in Colombia. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Universidad de la Sabana · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Mar 2025, registered May 2026).
Updated Oct 21, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Non-randomized
Sex
All
01

Study summary

Introduction: Type 1 diabetes mellitus is a health condition that produces physical and psychosocial alterations in both the person the person with diabetes mellitus and his or her family, that is why interventions should be designed that make a comprehensive approach to the physiological and psychological aspects of adolescents and parents in order to achieve adaptation to a new normality in the framework of this health condition. Objective: To establish the preliminary efficacy of a comprehensive intervention to promote adaptation in adolescents with type 1 diabetes mellitus and their parents during the transfer of health care responsibility in Bogota, Colombia 2023-2025. Materials and methods: we propose to conduct a pilot study that will develop and evaluate a comprehensive intervention to promote adaptation in adolescents with DM1 and their parents. In the qualitative phase, the needs of adolescents with type 1 diabetes mellitus and their parents will be explored through focus groups. In the quantitative phase, the intervention will be designed and its feasibility, acceptability and preliminary efficacy will be evaluated. A content analysis will be performed on the qualitative data and descriptive and inferential statistical tools will be used for the quantitative data, considering the behavior of the data. Expected results: It is expected to evaluate the preliminary efficacy of a comprehensive intervention to promote adaptation in adolescents with diabetes.

02

Conditions studied

  • Type 1 Diabetes Mellitus (T1DM)
  • Parent
  • Adolescent
  • Nursing
03

In context

Diabetes Mellitus, Type 1

3,614 studies on the registry are indexed under Diabetes Mellitus, Type 1; 586 are open to participants now.

This study's enrollment of 34 is below the median of 40 across 2,718 interventional studies indexed under Diabetes Mellitus, Type 1.

Browse Diabetes Mellitus, Type 1 studies →

Lead sponsor

Universidad de la Sabana is the lead sponsor of 23 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • -Adolescents aged 12 to 16 years with a diagnosis of DM1.
  • Adolescents diagnosed with DM1 for at least 12 months prior to study enrollment
  • Parents of adolescents aged 12 to 16 years with DM1

Exclusion criteria

Exclusion Criteria:

  • Adolescents with other endocrine pathologies.
  • Adolescents and parents participating in an intervention other than institutional management
  • Parents and adolescents with a diagnosis of cognitive disease that prevents them from participating in the study.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
34 participants (actual)

Study arms

  • Experimental
    Comprehensive Nursing Intervention Group

    Comprehensive nursing intervention consisting of 8 sessions delivered over 8 weeks.

    Behavioral: CONEXIÓN ADAPTAR - DM1

  • Active comparator
    Standard Usual Care

    Standard care consisting of quarterly check-ups with specialists, an annual multidisciplinary assessment, and a 24-hour annual educational program (excluding initial education at diagnosis).

    Other: Usual Care

Interventions

  • BehavioralCONEXIÓN ADAPTAR - DM1

    Intervention CONEXIÓN ADAPTAR - DM1, consists of 8 sessions for adolescents and parents, the intervention is delivered in person and virtually and seeks to promote adaptation to type 1 Diabetes.

  • OtherUsual Care

    Usual care

06

What researchers measure

Primary outcomes

  1. Adolescent Glycated Hemoglobin (HbA1c)

    Level of glycated hemoglobin (HbA1c) measured in percentage (%) to evaluate glycemic control in adolescents.

    Time frame: Three months after baseline assessment.

  2. Adolescent Self-Concept Score

    Self-concept score measured using the Visual Analog Scale 4 (EVA-4). Scores range from 0 to 10, where higher scores represent a better self-concept.

    Time frame: Baseline, 3 months post-baseline.

  3. Adolescent Health Self-Management

    Health self-management measured using the Flinders Living with Diabetes scale. Total scores range from 0 to 84, where higher scores indicate greater self-management ability.

    Time frame: Baseline, 3 months post-baseline.

  4. Parental Sleep Quality Score

    Sleep quality measured using the Pittsburgh Sleep Quality Index (PSQI). Total scores range from 0 to 21, where lower scores indicate better sleep quality.

    Time frame: Baseline, 3 months post-baseline.

  5. Parental Stress Score Assessed by the Parenting Stress Index-Short Form

    Parental stress measured using the Parenting Stress Index-Short Form (PSI/SF). Total scores range from 36 to 180, where lower scores represent lower parental stress.

    Time frame: 3 months after baseline

07

Study locations

2 sites
  • Universidad de La Sabana
    Chía, Cundinamarca 250001, Colombia
  • Universidad de La Sabana
    Chía, 250001, Colombia
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07886307
Lead sponsor
Universidad de la Sabana
Responsible party
Sponsor
First posted
Oct 21, 2026
Start date
Mar 1, 2025
Primary completion
Sep 30, 2025
Completion
Dec 31, 2025
Last update
Oct 21, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion